The myasthenia gravis treatment market is anticipated to grow at a CAGR of 7.14% from US$1.973 billion in 2025 to US$2.785 ...

As a result, the muscles become weak when a person performs repeated physical movements. The disease is neither contagious nor inherited but it is often misunderstood as a psychological issue or ...

Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients ...

Marla Black Morgan, MD, with Phoebe Neurology Associates, presented findings on a study into the diagnostic journey of ...

The newly approved prefilled syringe for self-injection of Vyvgart Hytrulo will provide more convenience and flexibility for ...

Parkinson’s disease often starts much before the typical ... Before the more obvious motor symptoms kick in, Parkinson’s often announces itself through subtle changes like smaller handwriting ...

Even when symptoms are present, they’re oftentimes subtle or mistaken for other conditions, allowing the disease to go undiagnosed for extended periods. While these symptoms can stem from other health ...

Symptoms of the disease can include chest pain, fatigue, swelling of the legs, feet, and abdomen, and heart palpitations, among others. Recently, Pearce revealed that doctors ignored her symptoms ...

Chinese biotech RemeGen (SHA: 688331) has reported positive late-stage clinical trial data for its dual-target fusion protein ...

According to the presented data, among the participants in the Telitacicept 240 mg group, 98.1% of the patients demonstrated a ≥ 3-point reduction in Myasthenia ... down disease progression in the ...

SAN DIEGO -- Inebilizumab (Uplizna) improved function and reduced disease severity for up to 52 weeks in generalized myasthenia gravis (gMG) patients who were acetylcholine receptor (AChR ...